| Change Notification | Applies to: * | Date | ||||||
|---|---|---|---|---|---|---|---|---|
| BM-DSG | CB-DSG | GDRI | TD-DSG | TL-DSG | WB-DSG | Red Book | ||
| No. 34 - 2019 Platelets in Plasma and Additive Solution for Neonatal Use, Leucocyte Depleted |
⬤ | 26.11.19 | ||||||
| No. 33 - 2019 West Nile Virus |
⬤ | 22.08.19 | ||||||
| No. 32 - 2019 Ocular Surgery |
⬤ | 27.08.19 | ||||||
| No. 31 - 2019 Laser Treatment |
⬤ | 27.08.19 | ||||||
| No. 30 - 2019 Tropical Virus Risks |
⬤ | 31.08.19 | ||||||
| No. 29 - 2019 Timor |
⬤ | 31.08.19 | ||||||
| No. 28 - 2019 Former Yugoslav Republic of Macedonia |
⬤ | 31.08.19 | ||||||
| No. 27 - 2019 Palpitations and Arrythmias |
⬤ | 31.08.19 | ||||||
| No. 26 - 2019 Familial Psuedohyperkalaemia |
⬤ | 31.08.19 | ||||||
| No. 25 - 2019 United States of America |
⬤ | 31.08.19 | ||||||
| No. 24 - 2019 Oman |
⬤ | 31.08.19 | ||||||
| No. 23 - 2019 Sexually Transmitted Disease |
⬤ | ⬤ | ⬤ | ⬤ | 27.08.19 | |||
| No. 22 - 2019 Malignancy |
⬤ | 27.08.19 | ||||||
| No. 21 - 2019 Maligancy |
⬤ | 27.08.19 | ||||||
| No. 20 - 2019 Inflammatory Bowel Disease |
⬤ | ⬤ | ⬤ | ⬤ | 27.08.19 | |||
| No. 19 - 2019 Hepatitis C |
⬤ | ⬤ | ⬤ | ⬤ | 27.08.19 | |||
| No. 18 - 2019 Eye Disease |
⬤ | 27.08.19 | ||||||
| No. 17 - 2019 Complementary Therapy |
⬤ | ⬤ | ⬤ | ⬤ | 27.08.19 | |||
| No. 16 - 2019 Surgery |
⬤ | ⬤ | 12.11.19 | |||||
| No. 15 - 2019 Viral Haemorrhagic Fever |
⬤ | ⬤ | ⬤ | ⬤ | 09.04.19 | |||
| No. 14 - 2019 Tissue Safety Entry |
⬤ | ⬤ | ⬤ | ⬤ | 09.04.19 | |||
| No. 13 - 2019 Pre- and Post-Exposure Prophylaxis for HIV |
⬤ | ⬤ | ⬤ | ⬤ | 09.04.19 | |||
| No. 12 - 2019 Hepatitis A |
⬤ | ⬤ | ⬤ | ⬤ | 09.04.19 | |||
| No. 11 - 2019 Hepatisis C - Northern Ireland |
⬤ | 09.04.19 | ||||||
| No. 10 - 2019 HTLV |
⬤ | 09.04.19 | ||||||
| No. 09 - 2019 Cervical Carcinoma in Situ |
⬤ | 09.04.19 | ||||||
| No. 08 - 2019 Blood Safety Entry - England, Scotland, Wales |
⬤ | 09.04.19 | ||||||
| No. 07 - 2019 Blood Safety Entry - Northern Ireland |
⬤ | 09.04.19 | ||||||
| No. 06 - 2019 Tropical Virus Risks |
⬤ | 09.04.19 | ||||||
| No. 05 - 2019 Cape Verde |
⬤ | 09.04.19 | ||||||
| No. 04 - 2019 Pre- and Post-Exposure Prophylaxis for HIV |
⬤ | 09.04.19 | ||||||
| No. 03 - 2019 Pregancy |
⬤ | 09.04.19 | ||||||
| No. 02 - 2019 Malignancy |
⬤ | 09.04.19 | ||||||
| No. 01 - 2019 Hepatitis C |
⬤ | 09.04.19 | ||||||
(*)
BM-DSG - Bone Marrow and Peripheral Blood Stem Cell Donor Selection Guidelines
CB-DSG - Cord Blood Donor Selection Guidelines
GDRI - Geographical Disease Risk Index
TD-DSG - Tissue (Deceased) Donor Selection Guidelines
TL-DSG - Tissue (Live) Donor Selection Guidelines
WB-DSG - Whole Blood and Components Donor Selection Guidelines
Red Book - Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK